Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • October 2003 | Volume 16 - Issue 10
    By Anthony C. Yung, DPM, and John S. Steinberg, DPM
    23,268 reads | 1 comments | 10/03/03
    Surgical debridement of infected bone is an unfortunate reality for those of us who frequently treat patients with diabetes. While adequate debridement is the most important step in treating osteomyelitis, many authors have commented on the adjunctive role of antibiotics in this clinical dilemma.1-3 Systemic antibiotics are routinely used preoperatively and have been advocated for six weeks or more. However, infected bone may become devascularized, making the delivery of systemic antibiotics less than desirable. Delivering systemic antibiotics may also be compromised when there is a ... continue reading
    By Jonathan Moore, DPM, MS and Kimberly Moore, OTR
    33,469 reads | 3 comments | 10/03/03
    If you as a podiatric physician have not established yourself as the expert of the diabetic foot within your area, now is the time. There is no reason why you shouldn’t be the “go to” guy or gal in your community when it comes to treating, managing and preventing diabetes-related lower extremity complications. Managing the diabetic foot is all about a team approach and establishing yourself as the quarterback will not only improve the quality of care for your patients but it can also greatly enhance your business. The podiatric literature is replete with dozens of studies demonstrating ... continue reading
    By Robi Garthwait, Contributing Editor
    6,264 reads | 0 comments | 10/03/03
    The average person takes 8,000 to 10,000 steps a day, according to the American Podiatric Medical Association (APMA). Add in exercise, poor-fitting shoes and possible diabetes-related complications, and it is no wonder that 5 percent of the United States population have corns or calluses. With this in mind, Xenna Corporation introduced the Callex ointment earlier this year. The acid-free ointment uses natural plant enzymes to exfoliate hyperkeratotic tissue. Those who have used the product cite ease of use, quick results and overall effectiveness wherever dry, thickened skin is a problem. ... continue reading